Search

Your search keyword '"Clerico, Marinella"' showing total 355 results

Search Constraints

Start Over You searched for: Author "Clerico, Marinella" Remove constraint Author: "Clerico, Marinella" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
355 results on '"Clerico, Marinella"'

Search Results

1. ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis

2. SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose

3. Signs and symptoms of COVID‐19 in patients with multiple sclerosis

4. Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study

5. The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis

7. Sex effects across the lifespan in women with multiple sclerosis

9. Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study

11. The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study

12. Disability assessment using Google Maps

16. MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study

18. Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

19. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

20. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

21. Correction to: Disability assessment using Google Maps

25. Cladribine vs other drugs in MS: Merging randomized trial with real-life data

26. Sars-CoV2 infection in pregnant women with multiple sclerosis

27. Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression

28. Antibody response elicited by the SARS‐CoV‐2 vaccine booster in patients with multiple sclerosis: Who gains from it?

29. The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study

31. Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis

32. Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study

33. Associations between socioemotional alterations, quality of life, and social functioning in multiple sclerosis: A scoping review.

35. Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies

36. Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy

39. Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis

41. Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up

42. sj-docx-1-msj-10.1177_13524585221102918 – Supplemental material for Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies

44. Correction to: Disability assessment using Google Maps

45. In vivo evidence of functional disconnection between brainstem monoaminergic nuclei and brain networks in multiple sclerosis

46. Waxing and waning ataxia

49. Digital work engagement among Italian neurologists

50. Telemedicine in Parkinson's Disease: How to Ensure Patient Needs and Continuity of Care at the Time of COVID-19 Pandemic

Catalog

Books, media, physical & digital resources